.by Dennis Crouch.The USPTO possesses two conventional features: (1) quality evaluation to make certain treatments satisfy the asking for statutory needs of patentability as well as (2) well-timed as well as reliable processing of those applications. Current data proposes the Office is dealing with the next of these mandates, as mirrored in a sharp uptick in License Condition Correction (PTA) awards. [Graphes listed below]